189 related articles for article (PubMed ID: 30106443)
1. Higenamine enhances the antitumor effects of cucurbitacin B in breast cancer by inhibiting the interaction of AKT and CDK2.
Jin ZQ; Hao J; Yang X; He JH; Liang J; Yuan JW; Mao Y; Liu D; Cao R; Wu XZ; Li X; Chen D
Oncol Rep; 2018 Oct; 40(4):2127-2136. PubMed ID: 30106443
[TBL] [Abstract][Full Text] [Related]
2. Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2/REST pathway in human breast cancer.
Xiong J; Su T; Qu Z; Yang Q; Wang Y; Li J; Zhou S
Oncotarget; 2016 Apr; 7(17):23933-46. PubMed ID: 27004407
[TBL] [Abstract][Full Text] [Related]
3. Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer.
Huang S; Wang D; Zhang S; Huang X; Wang D; Ijaz M; Shi Y
Cancer Chemother Pharmacol; 2017 Oct; 80(4):685-696. PubMed ID: 28779263
[TBL] [Abstract][Full Text] [Related]
4. Cucurbitacin B inhibits human breast cancer cell proliferation through disruption of microtubule polymerization and nucleophosmin/B23 translocation.
Duangmano S; Sae-Lim P; Suksamrarn A; Domann FE; Patmasiriwat P
BMC Complement Altern Med; 2012 Oct; 12():185. PubMed ID: 23062075
[TBL] [Abstract][Full Text] [Related]
5. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
6. [Effects of cucurbitacin B on cell proliferation and apoptosis in Hep-2 cells].
Liu T; Zhang M; Deng Y; Zhang H; Sun C; Yang X; Ji W
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 May; 22(9):403-7. PubMed ID: 18652313
[TBL] [Abstract][Full Text] [Related]
7. Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin.
Liu T; Peng H; Zhang M; Deng Y; Wu Z
Eur J Pharmacol; 2010 Sep; 641(1):15-22. PubMed ID: 20483353
[TBL] [Abstract][Full Text] [Related]
8. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
9. Cucurbitacin D impedes gastric cancer cell survival via activation of the iNOS/NO and inhibition of the Akt signalling pathway.
Zhang YZ; Wang CF; Zhang LF
Oncol Rep; 2018 Jun; 39(6):2595-2603. PubMed ID: 29658590
[TBL] [Abstract][Full Text] [Related]
10. LW-213 induces G2/M cell cycle arrest through AKT/GSK3β/β-catenin signaling pathway in human breast cancer cells.
Zhao L; Miao HC; Li WJ; Sun Y; Huang SL; Li ZY; Guo QL
Mol Carcinog; 2016 May; 55(5):778-92. PubMed ID: 25945460
[TBL] [Abstract][Full Text] [Related]
11. Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells.
Rajput S; Kumar BN; Dey KK; Pal I; Parekh A; Mandal M
Life Sci; 2013 Nov; 93(21):783-90. PubMed ID: 24044882
[TBL] [Abstract][Full Text] [Related]
12. Cucurbitacin B inhibits the translational expression of hypoxia-inducible factor-1α.
Ma J; Zi Jiang Y; Shi H; Mi C; Li J; Xing Nan J; Wu X; Joon Lee J; Jin X
Eur J Pharmacol; 2014 Jan; 723():46-54. PubMed ID: 24333213
[TBL] [Abstract][Full Text] [Related]
13. Diosgenin targets Akt-mediated prosurvival signaling in human breast cancer cells.
Srinivasan S; Koduru S; Kumar R; Venguswamy G; Kyprianou N; Damodaran C
Int J Cancer; 2009 Aug; 125(4):961-7. PubMed ID: 19384950
[TBL] [Abstract][Full Text] [Related]
14. Differential Anticancer Activity of Pterostilbene Against Three Subtypes of Human Breast Cancer Cells.
Wakimoto R; Ono M; Takeshima M; Higuchi T; Nakano S
Anticancer Res; 2017 Nov; 37(11):6153-6159. PubMed ID: 29061796
[TBL] [Abstract][Full Text] [Related]
15. 4-Acetylantroquinonol B induced DNA damage response signaling and apoptosis via suppressing CDK2/CDK4 expression in triple negative breast cancer cells.
Satriyo PB; Su CM; Ong JR; Huang WC; Fong IH; Lin CC; Aryandono T; Haryana SM; Deng L; Huang CC; Tzeng YM; Chao TY; Liu HW; Yeh CT
Toxicol Appl Pharmacol; 2021 Jul; 422():115493. PubMed ID: 33727089
[TBL] [Abstract][Full Text] [Related]
16. Isoobtusilactone A induces cell cycle arrest and apoptosis through reactive oxygen species/apoptosis signal-regulating kinase 1 signaling pathway in human breast cancer cells.
Kuo PL; Chen CY; Hsu YL
Cancer Res; 2007 Aug; 67(15):7406-20. PubMed ID: 17671211
[TBL] [Abstract][Full Text] [Related]
17. Polyporus umbellatus inhibited tumor cell proliferation and promoted tumor cell apoptosis by down-regulating AKT in breast cancer.
Tan XL; Guo L; Wang GH
Biomed Pharmacother; 2016 Oct; 83():526-535. PubMed ID: 27447121
[TBL] [Abstract][Full Text] [Related]
18. Cucurbitacin B Induces Hypermethylation of Oncogenes in Breast Cancer Cells.
Dittharot K; Dakeng S; Suebsakwong P; Suksamrarn A; Patmasiriwat P; Promkan M
Planta Med; 2019 Mar; 85(5):370-378. PubMed ID: 30463098
[TBL] [Abstract][Full Text] [Related]
19. Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo.
Chen J; Zeng J; Xin M; Huang W; Chen X
Horm Metab Res; 2011 Sep; 43(10):681-6. PubMed ID: 21932171
[TBL] [Abstract][Full Text] [Related]
20. Higenamine reduces HMGB1 during hypoxia-induced brain injury by induction of heme oxygenase-1 through PI3K/Akt/Nrf-2 signal pathways.
Ha YM; Kim MY; Park MK; Lee YS; Kim YM; Kim HJ; Lee JH; Chang KC
Apoptosis; 2012 May; 17(5):463-74. PubMed ID: 22183510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]